We found that JVG045 is able to inhibit both K-RAS mutated ovarian (OVCAR5) and lung cancer cell lines (A549) in a dose-dependent manner (Supplementary Fig. 5 and Supplementary Table 2). Here, KRAS is linked to lung carcinoma.